Report

Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness


Released:

Report at a Glance

  • ME/CFS Clinicians’ Guide (PDF)
  • Report Brief (PDF)
  • Key Facts (PDF)
  • Diagnostic Algorithm (HTML)
  • Proposed-Diagnostic-Criteria (HTML)
  • Presentation (PDF)

Download an introductory slide for this report >>

Between 836,000 and 2.5 million Americans suffer from myalgic encephalomyelitis/chronic fatigue syndrome—commonly referred to as ME/ CFS. This disease is characterized by profound fatigue, cognitive dysfunction, sleep abnormalities, autonomic manifestations, pain, and other symptoms that are made worse by exertion of any sort. ME/CFS can severely impair patients’ ability to conduct their normal lives.

The Department of Health and Human Services (HHS), the National Insti­tutes of Health, the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, the Food and Drug Administration, and the Social Security Administration asked the Institute of Medicine (IOM) to convene an expert committee to examine the evidence base for ME/CFS. In Beyond Myal­gic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness, the com­mittee proposes new diagnostic criteria that will facilitate timely diagnosis and care and enhance understanding among health care providers and the public.